Literature DB >> 1741054

AIDS vaccine developments.

A Osterhaus, P de Vries, J Heeney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1741054     DOI： 10.1038/355684b0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

1.  Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.

Authors:  J A Kovacs; M B Vasudevachari; M Easter; R T Davey; J Falloon; M A Polis; J A Metcalf; N Salzman; M Baseler; G E Smith
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

2.  Generation of CD8 suppressor factor and beta chemokines, induced by xenogeneic immunization, in the prevention of simian immunodeficiency virus infection in macaques.

Authors:  Y Wang; L Tao; E Mitchell; W M Bogers; C Doyle; C A Bravery; L A Bergmeier; C G Kelly; J L Heeney; T Lehner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

3.  Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5).

Authors:  E G Hulskotte; A M Geretti; K H Siebelink; G van Amerongen; M P Cranage; E W Rud; S G Norley; P de Vries; A D Osterhaus
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

4.  Cytoskeletal proteins bound to heat-shock protein 70 may elicit resistance to simian immunodeficiency virus infection of CD4(+) T cells.

Authors:  Lesley A Bergmeier; Kaboutar Babaahmady; Jeffrey Pido-Lopez; Kate J Heesom; Charles G Kelly; Thomas Lehner
Journal:  Immunology       Date:  2009-11-25       Impact factor: 7.397

5.  Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines.

Authors:  Z R Israel; P F Edmonson; D H Maul; S P O'Neil; S P Mossman; C Thiriart; L Fabry; O Van Opstal; C Bruck; F Bex
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

6.  Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry.

Authors:  A B Sabin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

7.  Sulfation of the human immunodeficiency virus envelope glycoprotein.

Authors:  H B Bernstein; R W Compans
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

8.  Antibodies to human and non-human primate cellular and culture medium components in macaques vaccinated with the simian immunodeficiency virus.

Authors:  L A Bergmeier; J Walker; L Tao; M Cranage; T Lehner
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

9.  Involvement of human leukocyte antigen class I molecules in human immunodeficiency virus infection of CD4-positive cells.

Authors:  M Benkirane; D Blanc-Zouaoui; M Hirn; C Devaux
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

10.  Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines.

Authors:  K H Siebelink; E Tijhaar; R C Huisman; W Huisman; A de Ronde; I H Darby; M J Francis; G F Rimmelzwaan; A D Osterhaus
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.